Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: Meta‐analysis of diagnostic accuracy studies

@article{Breton2019CognitiveTF,
  title={Cognitive tests for the detection of mild cognitive impairment (MCI), the prodromal stage of dementia: Meta‐analysis of diagnostic accuracy studies},
  author={Alexandre Breton and Daniel Casey and N. Arnaoutoglou},
  journal={International Journal of Geriatric Psychiatry},
  year={2019},
  volume={34},
  pages={233 - 242}
}
Mild cognitive impairment (MCI) is regarded as a prodrome to dementia. Various cognitive tests can help with diagnosis; meta‐analysis of diagnostic accuracy studies would assist clinicians in choosing optimal tests. 
Validation study of the Alzheimer's Disease Assessment Scale‐Cognitive Subscale for people with mild cognitive impairment and Alzheimer's disease in Chinese communities
TLDR
The validity of the Chinese version of Alzheimer's Disease Assessment Scale‐Cognitive Subscale (ADAS‐Cog) for the community‐dwelling older people in China is verified. Expand
Cognitive screening instruments to identify vascular cognitive impairment: A systematic review
TLDR
This work systematically reviewed the psychometric properties of brief CSIs for vascular mild cognitive impairment (VMCI) and vascular dementia (VaD) and found them to be suitable for VCI. Expand
Active case finding of dementia in ambulatory care settings: a comparison of three strategies
  • T. Liew
  • Medicine
  • European journal of neurology
  • 2020
TLDR
This diagnostic study compared the performance of the three strategies for detecting dementia (primary aim), as well as for detecting both mild cognitive impairment (MCI) and dementia (secondary aim). Expand
Comparing the Diagnostic Accuracy of Two Cognitive Screening Instruments in Different Dementia Subtypes and Clinical Depression
TLDR
The SMMSE is less suitable in MCI, vascular and Parkinson’s dementia, where alternatives including the Qmci screen may be used, and the influence of co-morbid depression on scores merits further investigation. Expand
Brief Cognitive Tests Used in Primary Care Cannot Accurately Differentiate Mild Cognitive Impairment from Subjective Cognitive Decline
TLDR
There is a great need to further develop, validate, and implement accurate screening-tests for primary care to improve accurate identification of MCI among individuals that seek medical care due to cognitive symptoms. Expand
Predicting Cognitive Decline and Dementia with the Newly Normed SKT Short Cognitive Performance Test
TLDR
The newly normed SKT showed a high predictive validity for the onset of dementia, based on Kaplan-Meier estimators, and the trajectories of the different SKT traffic light labels were investigated over 3 years. Expand
Preventing dementia? Interventional approaches in mild cognitive impairment
TLDR
Interventional approaches in MCI from 2009 to April 2019 concerning the cognitive performance are presented and various forms and approaches of intervention have been suggested to delay cognitive decline. Expand
Symptom clusters of subjective cognitive decline amongst cognitively normal older persons and their utilities in predicting objective cognitive performance: structural equation modelling
TLDR
How the memory and non‐memory complaints ofSCD cluster with each other amongst community‐dwelling individuals was investigated, and the differential utility of the symptom clusters of SCD in predicting objective cognitive performance was evaluated. Expand
Psychometric Evaluation and Workflow Integration Study of a Tablet-Based Tool to Detect Mild Cognitive Impairment in Older Adults: Protocol for a Mixed Methods Study
TLDR
A preliminary evaluative study comparing the sensitivity, specificity, and reliability of the BrainFx Screen (referred to as SCREEN hereafter), a novel digital tool designed to assess functional competence and detect early signs of cognitive impairment, with the Quick Mild Cognitive Impairment, a validated and highly sensitive tool that detects MCI in the older adult population. Expand
CCCDTD5 recommendations on early and timely assessment of neurocognitive disorders using cognitive, behavioral, and functional scales
TLDR
Evidence‐based recommendations for detection, assessment, and monitoring of neurocognitive disorders and neurodegenerative disease are provided, developed for use in Canada and may also be useful in other jurisdictions. Expand
...
1
2
3
4
...

References

SHOWING 1-10 OF 55 REFERENCES
The Montreal Cognitive Assessment, MoCA: A Brief Screening Tool For Mild Cognitive Impairment
TLDR
A 10‐minute cognitive screening tool (Montreal Cognitive Assessment, MoCA) to assist first‐line physicians in detection of mild cognitive impairment (MCI), a clinical state that often progresses to dementia. Expand
Screening for amnestic mild cognitive impairment and early Alzheimer's disease with M@T (Memory Alteration Test) in the primary care population
To design and validate a new screening test for amnestic Mild Cognitive Impairment (A‐MCI) and early stage Alzheimer's disease (AD).
Rate of progression of mild cognitive impairment to dementia – meta‐analysis of 41 robust inception cohort studies
TLDR
The objective of this study is to quantify the risk of developing dementia in those with mild cognitive impairment (MCI) and to establish a biomarker for dementia in these patients. Expand
The prevalence of mild cognitive impairment about elderly population in China: a meta‐analysis
  • H. Nie, Y. Xu, +5 authors Y. Wu
  • Medicine
  • International journal of geriatric psychiatry
  • 2011
TLDR
A systematic analysis of the prevalence of mild cognitive impairment in China found that it is higher in the rural areas than in the urban areas, and the prevalence is higher for women. Expand
The Mini‐Cog as a Screen for Dementia: Validation in a Population‐Based Sample
TLDR
The Mini‐Cog, a brief cognitive screening test, is tested in an epidemiological study of dementia in older Americans and shows promise as a screening test for Alzheimer's disease. Expand
The Addenbrooke's Cognitive Examination Revised (ACE‐R): a brief cognitive test battery for dementia screening
There is a clear need for brief, but sensitive and specific, cognitive screening instruments as evidenced by the popularity of the Addenbrooke's Cognitive Examination (ACE).
Exploring the validity of mild cognitive impairment (MCI) subtypes: Multiple-domain amnestic MCI is the only identifiable subtype at longitudinal follow-up
TLDR
The findings suggest that the a-MCI+ subtype is the only variant that is recognizable via neuropsychological testing and the differentiation between single-domain subtypes and healthy controls is difficult and may not be achievable through current Neuropsychological assessment practices. Expand
Mild cognitive impairment as a diagnostic entity
TLDR
It is suggested that the diagnosis of mild cognitive impairment can be made in a fashion similar to the clinical diagnoses of dementia and AD, and an algorithm is presented to assist the clinician in identifying subjects and subclassifying them into the various types of MCI. Expand
Recall Tests Are Effective to Detect Mild Cognitive Impairment: A Systematic Review and Meta-analysis of 108 Diagnostic Studies.
BACKGROUND Mild cognitive impairment (MCI) is a prevalent symptom associated with the increased risk of dementia. There are many cognitive tests available for detection of MCI, and investigation ofExpand
Comparison of the quick mild cognitive impairment (Qmci) screen and the SMMSE in screening for mild cognitive impairment
TLDR
The quick mild cognitive impairment (Qmci) screen is more sensitive than the SMMSE and ABCS 135 in differentiating MCI and NC, making it a useful test, for MCI in clinical practice, especially for older adults. Expand
...
1
2
3
4
5
...